Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Imaging”

2,439 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,439 results

Not applicableLooking for participantsNCT07335900
What this trial is testing

A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis

Who this might be right for
Severe Aortic Valve Stenosis
RenJi Hospital 25
Not applicableStudy completedNCT02144311
What this trial is testing

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 26
Post-approval studies (Phase 4)Looking for participantsNCT05376878
What this trial is testing

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain
City of Hope Medical Center 10
Not applicableStudy completedNCT00788489
What this trial is testing

A Prospective Study to Evaluate FDG-PET, Breast MRI, and Breast Ultrasonography in Monitoring Tumour Responses in Patients With Locally Advanced Breast Cancer (LABC) Undergoing Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Breast Cancer
Ontario Clinical Oncology Group (OCOG) 49
Not applicableStudy completedNCT05132335
What this trial is testing

A Repeatability Study of Fatty Acid Uptake Using PET/MR Imaging in Patients With T2DM and Non-diabetic Control Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Turku University Hospital 19
Early research (Phase 1)Study completedNCT04715750
What this trial is testing

Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity

Who this might be right for
Alzheimer DiseaseProgressive Supranuclear Palsy
Life Molecular Imaging GmbH 10
Testing effectiveness (Phase 2)Study completedNCT00181168
What this trial is testing

Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Johns Hopkins University 63
Early research (Phase 1)Looking for participantsNCT05629689
What this trial is testing

Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Who this might be right for
Malignant Solid TumorOncology
GE Healthcare 50
Not applicableEnded earlyNCT04874818
What this trial is testing

CD8+ T-cell PET/CT Imaging in COVID-19 Patients

Who this might be right for
Lymphopenia Due to COVID-19T-cellPET Imaging
Radboud University Medical Center 5
Very early researchEnded earlyNCT03757910
What this trial is testing

Brain Imaging in the Diabetes Prevention Program Outcomes Study

Who this might be right for
Alzheimer Disease
José A. Luchsinger 5
Testing effectiveness (Phase 2)Looking for participantsNCT06904313
What this trial is testing

Ultralow Dose PET Imaging for PSMA Expression

Who this might be right for
Healthy VolunteerProstate CA
Akiva Mintz 200
Early research (Phase 1)Study completedNCT01826110
What this trial is testing

PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Johns Hopkins University 21
Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Early research (Phase 1)UnknownNCT00563537
What this trial is testing

Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisBulbar DiseaseSpinal Disease
University Hospital, Tours 30
Early research (Phase 1)Study completedNCT05666687
What this trial is testing

An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain

Who this might be right for
Major Depressive Disorder
Novartis Pharmaceuticals 10
Not applicableStudy completedNCT01963221
What this trial is testing

Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly Patients

Who this might be right for
AgingInflammation
Central Hospital, Nancy, France 30
Early research (Phase 1)Ended earlyNCT07329621
What this trial is testing

A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults

Who this might be right for
Healthy Volunteers
Otsuka Pharmaceutical Development & Commercialization, Inc. 8
Not applicableUnknownNCT05535621
What this trial is testing

68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients

Who this might be right for
HER2-Positive Cancer
Tongji Hospital 100
Testing effectiveness (Phase 2)UnknownNCT04883814
What this trial is testing

18F-fluoroestradiol (FES) PET/CT for Breast Cancer

Who this might be right for
Breast Cancer
Hoag Memorial Hospital Presbyterian 124
Very early researchUnknownNCT04841421
What this trial is testing

Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Sinotau Pharmaceutical Group 30
Next Page